Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) currently has 5 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 30 Sep, 2025 | 54,239 | 5,644 | 11.61% | $747,142.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 19,864 | 19,864 | 0.00% | $273,627.00 |
| LPL Financial LLC | 30 Sep, 2025 | 14,200 | 14,200 | 0.00% | $196,386.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 12,710 | 0 | 0.00% | $175,079.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 7,500 | 7,500 | 0.00% | $103,313.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 3,378 | 96 | 2.93% | $46,718.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 880 | 450 | 104.65% | $12,170.00 |
| OSAIC HOLDINGS, INC. | 30 Sep, 2025 | 500 | 0 | 0.00% | $6,480.00 |
| Rockefeller Capital Management L.P. | 30 Sep, 2025 | 300 | 300 | 0.00% | $4,149.00 |
| JONES FINANCIAL COMPANIES LLLP | 30 Sep, 2025 | 172 | 0 | 0.00% | $2,413.00 |
| Clearstead Advisors, LLC | 30 Sep, 2025 | 150 | 150 | 0.00% | $2,075.00 |
| HARBOUR INVESTMENTS, INC. | 30 Sep, 2025 | 100 | 0 | 0.00% | $1,383.00 |
| WELLS FARGO & COMPANY/MN | 30 Sep, 2025 | 99 | -1 | -1.00% | $1,369.00 |
| UBS Group AG | 30 Sep, 2025 | 35 | -291 | -89.26% | $484.00 |
| Archer Investment Corp | 30 Sep, 2025 | 35 | 0 | 0.00% | $484.00 |
| IFP Advisors, Inc | 30 Sep, 2025 | 30 | 0 | 0.00% | $415.00 |
| Farther Finance Advisors, LLC | 30 Sep, 2025 | 25 | 0 | 0.00% | $346.00 |
| Carolina Wealth Advisors, LLC | 30 Sep, 2025 | 20 | 0 | 0.00% | $277.00 |
| CALDWELL SUTTER CAPITAL, INC. | 30 Sep, 2025 | 5 | 0 | 0.00% | $69.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 1 | -13 | -92.86% | $14.00 |